ETC
Exchange Traded Concepts’s Vanda Pharmaceuticals VNDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-235,356
| Closed | -$993K | – | 1441 |
|
2023
Q4 | $993K | Buy |
235,356
+1,894
| +0.8% | +$7.99K | 0.03% | 403 |
|
2023
Q3 | $1.01M | Buy |
+233,462
| New | +$1.01M | 0.03% | 385 |
|
2023
Q1 | – | Sell |
-55,749
| Closed | -$412K | – | 1292 |
|
2022
Q4 | $412K | Buy |
+55,749
| New | +$412K | 0.01% | 563 |
|
2022
Q3 | – | Sell |
-44,657
| Closed | -$487K | – | 1328 |
|
2022
Q2 | $487K | Buy |
44,657
+407
| +0.9% | +$4.44K | 0.01% | 522 |
|
2022
Q1 | $500K | Buy |
+44,250
| New | +$500K | 0.01% | 664 |
|
2021
Q3 | – | Sell |
-35,187
| Closed | -$757K | – | 1243 |
|
2021
Q2 | $757K | Buy |
35,187
+3,003
| +9% | +$64.6K | 0.02% | 383 |
|
2021
Q1 | $483K | Sell |
32,184
-24,812
| -44% | -$372K | 0.02% | 537 |
|
2020
Q4 | $749K | Buy |
56,996
+5,544
| +11% | +$72.9K | 0.03% | 267 |
|
2020
Q3 | $497K | Buy |
51,452
+35,268
| +218% | +$341K | 0.03% | 302 |
|
2020
Q2 | $185K | Buy |
+16,184
| New | +$185K | 0.03% | 483 |
|